🫁 Severe Asthma

FDA-Approved Biologic Treatment Options · Insurance & Savings · Free Delivery

About Severe Asthma

Severe asthma is a difficult-to-control form of asthma that persists despite high-dose inhaled corticosteroids and long-acting bronchodilators. Biologic therapies target specific inflammatory pathways driving uncontrolled asthma.

Common Symptoms

Frequent asthma attacks despite medication
Shortness of breath limiting daily activities
Frequent nighttime awakening with breathing difficulty
Recurrent need for oral corticosteroids
Chronic cough and chest tightness
Frequent emergency room visits or hospitalizations

Insurance & Savings for Severe Asthma Biologics

🛡️ Commercial Insurance

Most insured patients pay $0–$35/month through manufacturer copay programs. BiologicHealthPlus verifies your benefits at no charge.

🆓 Patient Assistance

Uninsured or income-eligible patients may receive biologic medications free of charge through manufacturer PAP programs.

📋 Prior Authorization

We file and manage all prior authorizations and insurance appeals for Severe Asthma biologics — completely free.

✅ BiologicHealthPlus Handles Everything

Insurance verification · Prior authorization · Copay enrollment · Free cold-chain delivery to all 50 states · 24/7 pharmacist support

Check my coverage →

💊 FDA-Approved Biologics for Asthma

Dupixent (Dupilumab) Nucala (Mepolizumab) Fasenra (Benralizumab) Xolair (Omalizumab)

Check My Coverage →

📞 Call a Pharmacist

Biologic Medications for Severe Asthma

BiologicHealthPlus carries all FDA-approved biologic medications for Severe Asthma. Click any medication to learn about dosage, mechanism, storage, costs, and savings programs.

Browse All Medications →

Frequently Asked Questions About Severe Asthma

FDA-approved biologics for severe asthma include Dupixent (Dupilumab) for type 2 asthma, Nucala (Mepolizumab) and Fasenra (Benralizumab) for eosinophilic asthma, and Xolair (Omalizumab) for allergic asthma. BiologicHealthPlus carries Dupixent for asthma and can help you navigate coverage for other asthma biologics.

Cash prices for asthma biologics range from $1,500–$4,500/month. With insurance and manufacturer savings programs, most patients pay significantly less. BiologicHealthPlus verifies your coverage and enrolls you in available savings.

Biologics for asthma are typically recommended for patients with severe, uncontrolled asthma who continue to have frequent exacerbations despite optimal inhaler therapy. Blood eosinophil counts, IgE levels, and other biomarkers help identify the right biologic.

Yes. Dupixent (Dupilumab) is FDA-approved for moderate-to-severe asthma and has been shown to significantly reduce asthma attacks, improve lung function, and reduce oral corticosteroid use in clinical trials — particularly in patients with type 2 (eosinophilic or allergic) asthma.

Free Cold-Chain Delivery for Severe Asthma Medications

🚚 Free Delivery

All Severe Asthma biologics ship free in temperature-controlled packaging to all 50 states.

⏱️ Fast Turnaround

Most prescriptions are processed and shipped within 1–2 business days of insurance verification.

🌡️ Temperature Guaranteed

Our cold-chain packaging maintains the required 36°F–46°F throughout transit.

💬 24/7 Support

BiologicHealthPlus pharmacists are available 24/7 by phone, WhatsApp, and email.

Many autoimmune conditions are related and share treatment options. Explore:

Atopic Dermatitis · Plaque Psoriasis · Chronic Rhinosinusitis

📚 Sources & Further Reading

BiologicHealthPlus follows medical consensus from leading health organizations. The following authoritative sources were used in developing this page:

🔗

Asthma StatisticsCDC

🔗

AsthmaWikipedia

🔗

Asthma Clinical ReviewNIH / NCBI

🔗

Asthma LibraryAAAAI

Medical Disclaimer: Content is for educational purposes only and reviewed by the BiologicHealthPlus Clinical Team. Always consult your healthcare provider for personalized medical advice. Last reviewed: August 2026.

Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions. Last reviewed: July 2026 by the BiologicHealthPlus Clinical Team.